Hardly a week goes by without someone asking me about a new weight loss medicine. Over the past couple of years, I've watched the conversation around weight loss treatment change faster than at any other point in my career. Several pharmaceutical companies, including Novo Nordisk, Eli Lilly and Pfizer, are investing heavily in new treatments, and the UK now has its first MHRA-approved oral GLP-1 medicine licensed specifically for weight management: the oral Wegovy pill. I want to explain, in plain terms, why this field has become so competitive, what has actually changed here in the UK, and what I think is worth considering if you are weighing up whether treatment might be right for you. This is general information from my professional perspective, not personal medical advice, so please still speak to your own prescriber before making any decisions.
Why Has Weight Loss Become Such a Priority for Pharmaceutical Companies?
From what I see every day, it really comes down to scale. Obesity